Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
about
Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.The evolving concept of acute kidney injury in patients with cirrhosis.Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.Perspective on Clinical Application of Biomarkers in AKI.Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.Why and how to measure renal function in patients with liver disease.Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.Hepatorenal syndrome: Update on diagnosis and therapy.Fluid balance concepts in medicine: Principles and practice.Neutrophil gelatinase-associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.Involvement of Pro-Inflammatory Macrophages in Liver Pathology of Pirital Virus-Infected Syrian Hamsters.Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment
P2860
Q30251763-F8699D91-B88C-469F-A223-4DCF3E54B3B9Q36064692-933B24AB-9EEF-4B1C-BBE4-F7D80B4E4375Q38611893-86D9177C-8C6C-468E-B0A8-608EDF4B2325Q38763423-808D34A3-4A88-4590-9BFC-2409BB06AB68Q38850006-03EE8620-1F8F-4AC0-9885-94ECE6A0EE89Q38951140-CA9565AC-AD07-44EB-8A61-0052D14E8E31Q39053064-BF852173-AAEF-4E2B-8C24-5404AE1119E3Q39067350-C1B1D377-0947-4AB1-8CC2-4632064CBAF8Q39323851-F965F1D1-0A63-441C-B6A9-4A1179BE1652Q42318961-899B425A-DD8A-49C2-B18C-912D11AC0BE3Q47705540-29A63C95-1EB9-4955-B84C-20D490999770Q51630643-DD751389-FABF-4A49-AD57-E496570DD0D1Q54221793-2BE44D1B-A342-49E9-BD08-D2EB98F28123Q55259131-6E84C34C-92E4-4DB7-8258-C8D60A601476Q55406066-083BF906-5ECF-4772-B2C4-9DED1D28CF47Q57824694-BE9A9DF4-8F76-4F05-A0E9-B0035DBFA76D
P2860
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
@ast
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
@en
type
label
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
@ast
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
@en
prefLabel
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
@ast
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
@en
P2093
P2860
P50
P1433
P1476
Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis
@en
P2093
Chiara Elia
Cristina Solé
Ezequiel Rodríguez
Javier Fernández
Patricia Huelin
Pere Ginès
Rebeca Moreira
Rogelio Barreto
Xavier Ariza
P2860
P304
P356
10.1371/JOURNAL.PONE.0128145
P407
P577
2015-06-04T00:00:00Z